everyone. and Mike, good morning, Thanks,
progress As in you this making, that never quarter. we pleased has number are team the financial quite can our confidence the And imagine, second enterprise been patients delivered are has the serving, we the higher. expanded results and are the of we in overall with
to And earnings are the strong first growth here sit full continue in on based unique and momentum. initiatives the into invest year, national our We strategic upon scalable our earnings platform. half to important, growth revenue we expansion as increasing on translate to leveraged continue we platform. we our today, build expectations Equally for
to guided revenue also managing certain dynamics pandemic in growth. midst the were wave, XXXX, X% therapies. to second and for remained entered we chain we X% the we Consequently, we As supply of
above chronic through sequential momentum newer quarter, Recall to the given And balanced and comparative growth, quarters, onset so multiple is payer levels. myasthenia we quarter acute focused including and referral over sources. strong pre-COVID for and both to referral chronic offense, growth patterns both high some collaboration pre-COVID considerably and speak, growth The clearly single-digit portfolios, increased. we've Regardless, XXXX in therapies, quarter saw portfolios, sclerosis, strength therapies the past our challenging the we instances, we've for seen of prior second has team partners in the across and gravis. on the referral seen with pandemic. referrals our Over as patterns remained saw levels. the first the high acute few with several chronic we’ve in with over return on therapy year growth particular In disruptive has teens
our Our we resonating for referral expect first Despite full on topline unique the And year, with and now manufacturers, dynamic results remain results, strong topline a in affirm our that in we double-digit topline the very growth is half. based generate value momentum environment. generated to sources. the proposition, payers,
manage tight Our situation we strategic and immunoglobulins, risk to with companies, a we for most labor facing markets, supply chain is expertise, entering investments which respect we given continue the clinical highlighted clearly Like into especially to labor in our clinician. are year. challenging improving, skilled conditions as
to has that Health successfully referral with the over Option been labor the able of of reputation been Care navigate challenging have a We dependability challenging the far maintain to sources situation. pandemic thus hallmark market, the team
situation the deepening agencies. closely, with home efficiencies, enhancements, the situation to partnerships continue and are labor through technology talent monitor and development, we We proactively addressing health
our tuck-in efforts, in future complete. the of markets This acquisition, in for solid IG we closed geographic number the integration from and catalysts. and I'm invest to go-to-market BioCure on already us. that a Early key we growth reinforced has QX, the pleased to growth Aside continue second complementary quarter, the report strengthened in is
partners, technology with collaboration technology existing software. trusted patient engagement co-develop to a announced recently clinical also one our market-leading We management and AlayaCare, of
we suite, been introduce we of AlayaCare patient tens experience integrated quite a optimize improve millions articulated are while, dollars of with trenches experience, additional have families. excited the our and into patients on in technology the the for for our invested model. we efficient tools therapy to has operating As us have and their occasions, many to maintain and an to
will a and Over patient centers point, Kumbhat, perspective suite market Seema do, created Officer. with newly XX initiative profitability. of role improve helps standalone to in key I'm the are the industry. of invested this earlier team, I'm by raise in the infusion the labor experience The capacity partially to labor Seema we but past my infusion we year-end. thrilled a additional center our topline Mike patient unique and and higher to provides challenging currently a clinical Medical leverage face. moving addition my optimize open six is at everything brings of To Infusion encouraged the in the additional to minutes, few infusion very ability XX mitigate to forefront months, an by and as also we've efficiency, to we to deliver our experience Dr. workforce. to capacity, levels capacity continue center growth the Chief and the our of leadership results additional bar unpack aggressively is infrastructure, growth-enabling clinical the
implies started. for this been and team half the release of million first has have ability range increased the earnings flow delivering year. morning, margin in established full the based the announced The the quarter. the translate we're EBITDA guidance cash both EBITDA, significantly the to adjusted strong, operations guidance over in momentum north getting from flow of $XX our the quite of for cash our in the X% for to of we year midpoint on As an year, revenue and we And only
of strategy We market year four I of execute achieved light continued how mid-year. our to target of be in also and prouder the at full continue couldn't Again, times leverage dynamics. team they our
the Aduhelm for want I a minutes over Mike, Alzheimer's. Before on approval of I to turn few recent to spend
that what condition devastating As patients therapy. the challenging given fits site an for that are of their with day, setting, a preference complicating population, the patient patients every and an older conditions, well with and we clinically, a chronic encouraged conditions limited are alternate is for profile serves emerging families. many Aduhelm quite And new therapies organization with for travel for
Medicare. for infusion However, of at emerging the Medicare and covered as as therapy, home the population this levels site is for the reimburse not occasions, have to support far challenging currently reimbursement pathway communicated setting, home in the on by remains multiple we adequately majority alternate And targeted care. does
CMS coverage with work see to coalition the as from guidance the improvement benefit home Aduhelm determination, and of near-term a and to opportunity we legislative reflects the at this We not Aduhelm for any to time. continue In our payers current approach to do separately environment landscape, none until infusion. Medicare industry changes. reimbursement monitor seek a the Consequently, reimbursement
overall, into pleased quarter year. and second So, team, results, the positioned half where the are second of very with I’m the by heading the we the performance entire
in turn from You'll recall clearly, we a that quarter made that Mike to the detail. in results to that, pivoting the review With to first turn. we've call, call bit more integration over Mike? the I'll commented were and acceleration, I quickly